JAK inhibitors

Diagnosing Systemic Disease in Patients With Skin of Color
Systemic disease in skin of colorPigmentary change often drives patients to seek dermatologic care, yet sometimes the cause is more than skin deep. Next Steps in Derm, in partnership with Skin of Color Update, interviewed conference co-chair Dr. Andrew F. Alexis about the skin signs of systemic disease in patients with darker skin tones. Watch as Dr. Alexis shares stories of the diseases he’s diagnosed in clinical practice. Le …
Systemic disease in skin of color
Bridging the Gaps: Exploring the Links Between Prurigo Nodularis and Chronic Itch
image of a skin of color male with prurigo nodularis (PN) on his backPrurigo nodularis (PN) is far more than just a persistent itch—it is a distinct, neuroimmune-driven disease entity that demands its own targeted diagnostic and therapeutic roadmap. During a standout session at this year's Skin of Color Update in New York City, Dr. Raj Chovatiya challenged the long-held notion that PN is merely a variant of atopic dermatitis. For patients with skin of color, wher …
image of a skin of color male with prurigo nodularis (PN) on his back
Friday Pop Quiz 5/8/2026
A 40 year old male presents to clinic with involvement of greater than 50% of his scalp. Topical therapies and intralesional injections in clinic have not resulted in much improvement. Before starting the appropriate FDA approved long-term oral medication, which laboratory blood work should be ordered? A. Quantiferon gold test only B. Fasting glucose, Hemoglobin A1C, lipid panel, and cor …
JAK Inhibitors in Dermatology Patients With Skin of Color
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and …
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.
No Brainer Approaches to Neutrophilic Dermatoses
Neutrophilic DermatosesAt the 2025 ODAC Dermatology conference, Dr. Anthony Fernandez, MD, PhD gave an informative presentation titled, No-Brainer Approaches to Neutrophilic Dermatoses. His presentation focused on discussing the clinical presentation, differential diagnosis considerations, and treatment options of pyoderma gangrenosum and Sweet syndrome. Pyoderma Gangrenosum (PG) Pyoderma gangrenosum typically present …
Neutrophilic Dermatoses